References
- Board PG, Coggan M, Chelvawayagam G, Easteal S, Jermin LS, Schulte GK, Danley DE, Hoth LR, Griffor MC, Kamath AV, Rosner MH, Chrunyk BA, Perregaux DE, Gabel CA, Geoghegan KF, Pandit J. 2000. Identification, characterization, and crystal structure of the Omega class glutathione transferases. J Biol Chem 275:24798–24806.
- Budowle B, Moretti T, Smith J, Dizinno J. 2000. DNA typing protocols: Molecular biology and forensic analysis. Natick, MA: Eaton Publishing.
- Frova, C. 2006. Glutathione transferases in the genomic era: New insights and perspectives. Biomol Eng 23:149–169.
- Fujihara J, Kunito T, Takeshita, H. 2007. Frequency of two human glutathione-S-transferase omega-1 polymorphisms (E155 deletion and E208K) in Ovambo and Japanese populations using the PCR-based genotyping method. Clin Chem Lab Med 45:621–624.
- Hashimoto T, Hashimoto K, Miyatake R, Matsuzawa D, Sekine Y, Inada T, Ozaki N, Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Iyo M. 2008. Association study between polymorphisms in glutathione-related genes and metamphetamine use disorder in a Japanese population. Am J Med Gen 147B:1040–1046.
- Hayes JD, Flanagan JU, Jowsey IR. 2005. Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88.
- Marahatta SB, Punyarit P, Bhudisawasdi V, Paupairoj A, Wongkham S, Petmitr S. 2006. Polymorphism of glutathione S-transferase Omega gene and risk of cancer. Cancer Lett 236:276–281.
- Mukherjee B, Salavaggione OE, Pelleymounter LL, Moon I, Eckloff BW, Schaid DJ, Wieben ED, Weinshilboum RM. 2006. Glutathione S-transferase Omega 1 and Omega 2 pharmacogenomics. Drug Metab Dispos 34:1237–1246.
- Olsen A, Autrup H, Sørensen M, Overvad K, Tjønneland A. 2008. Polymorphisms of glutathione S-transferase A1 and O1 and breast cancer among postmenopausal Danish women. Eur J Canc Prev 17:225–229.
- Paiva L, Marcos R, Creus A, Coggan M, Oakley AJ, Board PG. 2008. Polymorphism of glutathione transferase Omega 1 in a population exposed to a high environmental arsenic burden. Pharmacogenet Genomics 18:1–10.
- Schmuck E, Board PG, Whitbread AK, Tetlow N, Cavanaugh JA, Blackburn AC, Masoumi A. 2005. Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: Implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases. Pharmacogenet Genomics 15:493–501.
- Schmuck E, Cappello J, Coggan M, Brew J, Cavanaugh JA, Blackburn AC, Baker RT, Eyre HJ, Sutherland GR, Board PG. 2008. Deletion of Glu155 causes a deficiency of glutathione transferase Omega 1-1 but does not alter sensitivity to arsenic trioxide and other cytotoxic drugs. Int J Biochem Cell Biol 40:2553–2559.
- Strange RC, Jones PW, Fryer AA. 2000. Glutathione S-transferase: Genetics and role in toxicology. Toxicol Lett 112–113:357–363.
- Takeshita H, Fujihara J, Takastuka H, Agusa T, Yasuda T, Kunito T. 2009. Diversity of glutathione S-transferase omega 1 (A140D) and 2 (N142D) gene polymorphisms in worldwide populations. Clin Exp Pharmacol Physiol 36:283–286.
- Whitbread AK, Tetlow N, Eyre HJ, Sutherland GR, Board PG. 2003. Characterization of the human Omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics 13:131–144.